Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2024, 6(4); doi: 10.25236/IJFM.2024.060406.

Correlation of blood glucose variability based on CGMS monitoring during cardiopulmonary bypass and postoperative delirium in patients with rheumatic heart disease valve replacement

Author(s)

Liu Dan, Liang Yu, Lin Lu

Corresponding Author:
Lin Lu
Affiliation(s)

Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu, Sichuan, 610083, China

Abstract

To investigate the relationship between blood glucose variability based on continuous glucose monitoring system (CGMS) monitoring and postoperative delirium (POD) in patients with rheumatic heart disease undergoing valve replacement during cardiopulmonary bypass. From July 2021 to July 2022, we conducted real-time dynamic blood glucose monitoring after admission to the operating room in 122 patients undergoing valve replacement for rheumatic heart disease. CGMS were used to record indicators related to blood glucose variation, including CV, GluAve, GluSD and MAGE, and MMSE was also used for evaluation one day before surgery. To rule out preoperative cognitive impairment. At postoperative days 1, 2, and 3, the CAM-ICU scale was used to assess patients' unconsciousness. Finally, binary logistic regression analysis was used to study the relationship between intraoperative blood glucose changes and POD. The age of patients with POD was significantly older than that of patients without POD, and the occurrence of POD was related to the duration of extracorporeal circulation and the value of the blood glucose variation index (CV, GluAve, GluSD, MAGE). By binary logistic regression analysis, we found that age, CPB cycle time and blood glucose variability were independent risk factors for postoperative delirium (POD) (P <0.05). In addition, we also found that the area under ROC curve of CV, GluAve, GluSD and MAGE were 0.684, 0.830, 0.820 and 0.802, respectively, which indicated that these indexes could predict the occurrence of postoperative delirium (POD). GluAve had the strongest prediction effect on POD (sensitivity 85.7%, specificity 81.5%). Blood glucose variability based on CGMS monitoring during cardiopulmonary bypass in patients with rheumatic heart disease valve replacement is associated with the occurrence of postoperative delirium. Longer duration of CPB and increased intraoperative blood glucose variability are independent risk factors for POD in patients with rheumatic heart disease valve replacement. Continuous monitoring of intraoperative blood glucose by CGMS can provide real-time guidance for early intervention of blood glucose fluctuations to reduce the incidence of postoperative POD.

Keywords

blood glucose variability; postoperative delirium; cardiopulmonary bypass; valve replacement

Cite This Paper

Liu Dan, Liang Yu, Lin Lu. Correlation of blood glucose variability based on CGMS monitoring during cardiopulmonary bypass and postoperative delirium in patients with rheumatic heart disease valve replacement. International Journal of Frontiers in Medicine (2024), Vol. 6, Issue 4: 44-50. https://doi.org/10.25236/IJFM.2024.060406.

References

[1] Windmann V, Spies C, Knaak C, et al. Intraoperative hyperglycemia increases the incidence of postoperative delirium. Minerva Anestesiol. 2019. 85(11): 1201-1210.

[2] Rudolph JL, Marcantonio ER. Review articles: postoperative delirium: acute change with long-term implications. Anesth Analg. 2011. 112(5): 1202-11.

[3] Tse L, Schwarz SK, Bowering JB, Moore RL, Barr AM. Incidence of and Risk Factors for Delirium after Cardiac Surgery at a Quaternary Care Center: A Retrospective Cohort Study. J Cardiothorac Vasc Anesth. 2015. 29(6): 1472-9.

[4] Zhang Zhiyuan, Xu Li, Du Hong, Gu Xiaowei. Retrospective analysis of adult patients with delirium after cardiopulmonary bypass. Chinese Nursing Medicine. 2022. 31(07): 773-776.

[5] Hermanides J, Qeva E, Preckel B, Bilotta F. Perioperative hyperglycemia and neurocognitive outcome after surgery: a systematic review. Minerva Anestesiol. 2018. 84(10): 1178-1188.

[6] Kotfis K, Szylińska A, Listewnik M, Brykczyński M, Ely EW, Rotter I. Diabetes and elevated preoperative HbA1c level as risk factors for postoperative delirium after cardiac surgery: an observational cohort study. Neuropsychiatr Dis Treat. 2019. 15: 511-521.

[7] Lin YJ, Lin LY, Peng YC, et al. Association between glucose variability and postoperative delirium in acute aortic dissection patients: an observational study. J Cardiothorac Surg. 2021. 16(1): 82.

[8] Yin Q, Ma J, Han X, et al. Spatiotemporal variations of vascular endothelial growth factor in the brain of diabetic cognitive impairment. Pharmacol Res. 2021. 163: 105234.

[9] Li X, Yin Q, Han X, et al. Dynamic expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor beta (PDGFRβ) in diabetic brain contributes to cognitive dysfunction. Brain Res Bull. 2021. 175: 99-106.

[10] Lachmann G, von Haefen C, Wollersheim T, Spies C. Severe perioperative hyperglycemia attenuates postoperative monocytic function, basophil count and T cell activation. Minerva Anestesiol. 2017. 83(9): 921-929.

[11] Choi H, Park CS, Huh J, et al. Intraoperative Glycemic Variability and Mean Glucose are Predictors for Postoperative Delirium after Cardiac Surgery: A Retrospective Cohort Study. Clin Interv Aging. 2022. 17: 79-95.

[12] Shanks AM, Woodrum DT, Kumar SS, Campbell DA Jr, Kheterpal S. Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery. BMC Anesthesiol. 2018. 18(1): 90.

[13] Davis G, Fayfman M, Reyes-Umpierrez D, et al. Stress hyperglycemia in general surgery: Why should we care. J Diabetes Complications. 2018. 32(3): 305-309.

[14] Cheng Jiangli, Dong Meiling, Zhang Zhongwei, Liao Xuelian, Yang Jiayin, Kang Yan. Correlation between postoperative blood glucose variability and delirium in the ICU in liver transplant patients. Journal of Sichuan University (Medical Science). 2020. 51(03): 416-421.

[15] Nagashima M, Takeshima K, Sasaki R, et al. Optimal time period for blood glucose level evaluation after total knee arthroplasty in patients without diabetes: a prospective, observational study. J Orthop Surg Res. 2022. 17(1): 124.

[16] Wu Wenxian, Jie Yingbiao, Li Lihua, Li Xiaofeng. The effect of real-time ambulatory glucose monitoring system and fingerstick blood glucose monitoring on blood glucose fluctuations was observed during intensive insulin pump therapy in patients with type 2 diabetes. Contemporary Medicine. 2021. 27(32): 34-36.

[17] Saisho Y. Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease. Int J Mol Sci. 2014. 15(10): 18381-406.

[18] Jiang J, Li S, Zhao Y, et al. Intensive glucose control during the perioperative period for diabetic patients undergoing surgery: An updated systematic review and meta-analysis. J Clin Anesth. 2021. 75: 110504.

[19] Klimontov VV, Saik OV, Korbut AI. Glucose Variability: How Does It Work. Int J Mol Sci. 2021. 22(15).

[20] Kim H, Han J, Jung SM, Park SJ, Kwon NK. Comparison of sevoflurane and propofol anesthesia on the incidence of hyperglycemia in patients with type 2 diabetes undergoing lung surgery. Yeungnam Univ J Med. 2018. 35(1): 54-62.

[21] Sulhan S, Lyon KA, Shapiro LA, Huang JH. Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets. J Neurosci Res. 2020. 98(1): 19-28.

[22] Yang Y, Liu Y, Zhu J, et al. Neuroinflammation-mediated mitochondrial dysregulation involved in postoperative cognitive dysfunction. Free Radic Biol Med. 2022. 178: 134-146.

[23] Yang ZY, Yuan CX. IL-17A promotes the neuroinflammation and cognitive function in sevoflurane anesthetized aged rats via activation of NF-κB signaling pathway. BMC Anesthesiol. 2018. 18(1): 147.

[24] Xia Y, Xu H, Jia C, et al. Tanshinone IIA Attenuates Sevoflurane Neurotoxicity in Neonatal Mice. Anesth Analg. 2017. 124(4): 1244-1252.

[25] Liu L, Shang L, Jin D, Wu X, Long B. General anesthesia bullies the gut: a toxic relationship with dysbiosis and cognitive dysfunction. Psychopharmacology (Berl). 2022. 239(3): 709-728.